There are different pharmacological options for obesity management, including orlistat, naltrexone-bupropion, phentermine-topiramate, and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) [5, 6]. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.